A Friendly Ghostwritten Paper for Paxil

Aug 21, 2009

Merck and Wyeth weren't the only ones. The Associated Press reports that GlaxoSmithKline had a ghostwriting program to support its antidepressant, Paxil. The program, called CASSPER, instructed salespeople to approach physicians and help them write and publish positive articles about the antidepressant.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Call for an End

Three US lawmakers call on the Trump Administration to end its program to collect DNA from detained migrants, the Hill reports.

Promising Vaccine Candidate

Researchers in the US have developed a promising candidate vaccine against African swine fever, according to Bloomberg News.

Going for a Header

Soccer players who head the ball a lot and who have a certain APOE allele may be more likely to have memory problems, according to HealthDay.

Cell Studies on CCLE Proteomics, Toxoplasma Parasite Differentiation, Autism-Related Genes

In Cell this week: a quantitative proteomic atlas based on the Cancer Cell Line Encyclopedia, gene regulation and differentiation in Toxoplasma gondii, and more.

Menu